Professors Bonnie Firestein from CBN and Nada Boustany from BME were awarded a NIH R21 grant ($431,444 total amount) from the National Institute of Neurological Disorders and Stroke for their project "Determining a Role for Protein Kinase A in Dendrite Development using a FRET-based Sensor".
April 27, 2021
April 19, 2021
A patent was issued to BME Professors Jeffrey Zahn and David Shreiber, MAE Professors Hao Lin and Jerry Shan, and former BME PhD student Mingde ‘Jack’ Zheng, entitled, "HIGH THROUGHPUT, FEEDBACK-CONTROLLED ELECTROPORATION MICRODEVICE FOR EFFICIENT MOLECULAR DELIVERY INTO SINGLE CELLS” (US Patent number 10,927,333). The invention describes using an intelligent, feedback controlled, microscale electroporation system for transfecting single cells in a continuous flow fashion with electrical monitoring of cell permeabilization.
April 14, 2021
Dynamic lateral support could improve quality of life for wheelchair users Ever since she was young, Department of Biomedical Engineering (BME) master's degree candidate Madara Dias has wanted to help people. “I set my heart on majoring in biomedical engineering so that I could continue helping people through my work,” she says. “I saw this as a career path that would allow me to make a direct and positive impact on people’s lives – and maybe even save lives.”
April 1, 2021
Their design of a cancer-diagnosing smartphone app able to classify breast tissue as benign or malignant with 96% accuracy captured first place for Rutgers’ Team Patho-ML in the Rice 360° Institute for Global Health student design competition. Now in its 11th year, the prestigious international competition, drew a record number of semifinalists from 23 universities in six countries.
February 15, 2021
The American Institute for Medical and Biological Engineering (AIMBE) announced the election of Professor Joseph Freeman to its Class of 2021 College of Fellows. Professor Freeman is recognized for developing innovative materials and scaffolds to replace tissue function while regenerating new, healthy cells and tissue for repair after injury.
November 12, 2020
Professor Yannis Androulakis has been elected as part of the leadership team of the International Society of Pharmacometrics - Quantitative Systems Pharmacology Special Interest Group. During his 4-year term, he will serve as the vice-Chair, chair-elect, Chair, past Chair) and will develop conference programming, review of working group efforts, plan activities for the American Conference of Pharmacometrics conferences, and identify initiatives the field should undertake in the future.
October 13, 2020
A TechAdvance award of $97,000 has been awarded to a team led by Professor Martin Yarmush. The funding, which is provided by the Rutgers Office of Research and Economic Development, is to further develop a miniaturized, hand-held, robotic device for autonomous venipuncture.
October 6, 2020
A patent was issued to Professor Martin Yarmush and colleagues entitled, “System and Method for Electrical Control of Bacteria” (US Patent number: 10660979). The invention describes a system and method for controlling microbial growth on and in medical devices and implants, especially biofilm infections, using pulsed electric fields. In a clinical setting, systemic microbial therapy can be combined with PEF to achieve a synergistic effect leading to improved control and even eradication of infections.
October 6, 2020
Ten years ago, Rutgers football star Eric LeGrand suffered a spinal cord injury (SCI) during a game at MetLife Stadium. Despite a poor prognosis, in the years since he has exceeded expectations for his recovery and rehabilitation – and has become a noted motivational speaker, entrepreneur, sports analyst, philanthropist, and author.
October 2, 2020
A patent was issued to Professor Martin Yarmush and colleagues entitled, "Lineage Differentiation of Encapsulated Embryonic Stem Cells” (US Patent number: 10668102). The microencapsulation of embryonic stem cells results in decreased cell aggregation and enhanced neural lineage differentiation through incorporating the soluble inducer retinoic acid into the permeable microcapsule system. This differentiation process can be augmented by differentiation pathway regulators such as PPAR agonists.